CristinaCusinMD
Psychiatry • Boston, MADirector of Translational Studies in Depression at Massachuseets General Hospital. Assistant Professor in Psychiatry at Harvard Medical School.
Dr. Cusin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114Phone+1 617-726-6421Fax+1 617-724-3028- Is this information wrong?
Education & Training
Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 2006 - 2010
University of Milan Faculty of MedicineClass of 1997
Certifications & Licensure
MA State Medical License 2009 - 2024- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression Start of enrollment: 2010 Nov 01
- Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression Start of enrollment: 2012 Apr 01
- Neurobiological Bases of Placebo Response in Major Depressive Disorder Start of enrollment: 2012 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsBrain ventricle and choroid plexus morphology as predictor of treatment response in major depression: Findings from the EMBARC study.Murck, H., Fatt, C., Fava, M., Cusin, C., Trivedi, M.> ;Brain, Behavior, & Immunity - Health. 2024 Feb 1
- 6 citationsDiagnosis and Treatment of Bipolar Disorder: A Review.Andrew A Nierenberg, Bruno Agustini, Ole Köhler-Forsberg, Cristina Cusin, Douglas Katz, Louisa G Sylvia, Amy Peters, Michael Berk> ;JAMA. 2023 Oct 10
- 2 citationsBrain Ventricle and Choroid Plexus Morphology as Predictor of Treatment Response: Findings from the EMBARC Study.Harald Murck, Maurizio Fava, Cristina Cusin, Cherise Chin Fatt, Madhukar Trivedi> ;Research Square. 2023 Mar 1
- Join now to see all
Journal Articles
- Double-Blind, Placebo-Controlled, Dose-Ranging Trial of Intravenous Ketamine as Adjunctive Therapy in Treatment-Resistant Depression (TRD)Sanjay J Mathew, Madhukar H Trivedi, Lee C Chang, Dan V Iosifescu, Manish K Jha, Maurizio Fava, Marlene P Freeman, Cristina Cusin, James Murrough, George I Papakostas,..., Nature
Press Mentions
Atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine TreatmentNovember 17th, 2022- Placebo Effect Large in Treatment-Resistant DepressionSeptember 30th, 2021
- Low Doses of Nitrous Oxide May Treat DepressionJune 26th, 2021
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
